Esmero Research Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.85 M
- Company Age 10 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.00 Cr
- Revenue Growth 72.75%
- Profit Growth 37.27%
- Ebitda 442.91%
- Net Worth 26.38%
- Total Assets 76.92%
About Esmero Research
Esmero Research Private Limited (ERPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 05 December 2014 and has a history of Ten years and two months. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.85 M.
The company currently has active open charges totaling ₹4.00 Cr.
Vinitkumar Agrawal and Sneha Agrawal serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230GJ2014PTC081431
-
Company No.
081431
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Dec 2014
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Esmero Research?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinitkumar Agrawal
|
Director | 05-Dec-2014 | Current |
|
Sneha Agrawal
|
Director | 18-Jan-2020 | Current |
Financial Performance of Esmero Research.
Esmero Research Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 72.75% increase. The company also saw a substantial improvement in profitability, with a 37.27% increase in profit. The company's net worth Soared by an impressive increase of 26.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Esmero Research?
In 2023, Esmero Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Derek Healthcare Private LimitedVinitkumar Agrawal and Sneha Agrawal are mutual person
-
Delwis Healthcare Private LimitedVinitkumar Agrawal is a mutual person
-
Omshiv Impex Private LimitedVinitkumar Agrawal is a mutual person
Charges (Loans)
₹40.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 4.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 May 2024 | Others | ₹4.00 Cr | Open |
How Many Employees Work at Esmero Research?
Unlock and access historical data on people associated with Esmero Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Esmero Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Esmero Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
